Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL)
|2||Active, not recruiting||
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
|4||Active, not recruiting||
Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
† Study has passed its completion date and status has not been verified in more than two years.